KR920009806A - 아미노디올 유도체 - Google Patents
아미노디올 유도체 Download PDFInfo
- Publication number
- KR920009806A KR920009806A KR1019910020895A KR910020895A KR920009806A KR 920009806 A KR920009806 A KR 920009806A KR 1019910020895 A KR1019910020895 A KR 1019910020895A KR 910020895 A KR910020895 A KR 910020895A KR 920009806 A KR920009806 A KR 920009806A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- cycloalkyl
- different
- same
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEP4037437.8 | 1990-11-24 | ||
| DE4037437A DE4037437A1 (de) | 1990-11-24 | 1990-11-24 | Aminodiol-derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR920009806A true KR920009806A (ko) | 1992-06-25 |
Family
ID=6418858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019910020895A Withdrawn KR920009806A (ko) | 1990-11-24 | 1991-11-22 | 아미노디올 유도체 |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0487980A1 (enExample) |
| JP (1) | JPH04266877A (enExample) |
| KR (1) | KR920009806A (enExample) |
| CN (1) | CN1061778A (enExample) |
| AU (1) | AU8808691A (enExample) |
| CA (1) | CA2056063A1 (enExample) |
| CS (1) | CS354591A3 (enExample) |
| DE (1) | DE4037437A1 (enExample) |
| FI (1) | FI915495A7 (enExample) |
| HU (1) | HU208964B (enExample) |
| IE (1) | IE914081A1 (enExample) |
| MX (1) | MX9102186A (enExample) |
| NO (1) | NO914584L (enExample) |
| NZ (1) | NZ240693A (enExample) |
| PL (1) | PL292498A1 (enExample) |
| PT (1) | PT99585A (enExample) |
| TW (1) | TW206218B (enExample) |
| ZA (1) | ZA919245B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100709257B1 (ko) * | 2005-08-30 | 2007-04-19 | 삼성에스디아이 주식회사 | 연료 공급장치 및 이를 포함하는 연료 전지 시스템 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5888992A (en) * | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
| US6071895A (en) * | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
| ATE253050T1 (de) | 1992-03-11 | 2003-11-15 | Narhex Ltd | Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen |
| NZ249789A (en) * | 1992-03-11 | 1997-07-27 | Narhex Ltd | Hydrazine, carbazate and 1,2-diazacyclic derivatives and pharmaceutical compositions |
| US5691368A (en) * | 1995-01-11 | 1997-11-25 | Hoechst Marion Roussel, Inc. | Substituted oxazolidine calpain and/or cathepsin B inhibitors |
| KR20120130078A (ko) * | 2009-11-09 | 2012-11-28 | 메디비르 아베 | 신규한 1,3-옥사졸리딘 화합물 및 이의 레닌 억제제로서의 용도 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU632468B2 (en) * | 1988-02-01 | 1993-01-07 | Upjohn Company, The | Renin inhibiting peptides with polar end groups |
-
1990
- 1990-11-24 DE DE4037437A patent/DE4037437A1/de not_active Withdrawn
-
1991
- 1991-06-29 TW TW080105058A patent/TW206218B/zh active
- 1991-11-14 EP EP91119397A patent/EP0487980A1/de not_active Withdrawn
- 1991-11-21 FI FI915495A patent/FI915495A7/fi unknown
- 1991-11-22 NZ NZ240693A patent/NZ240693A/xx unknown
- 1991-11-22 AU AU88086/91A patent/AU8808691A/en not_active Abandoned
- 1991-11-22 CN CN91110931A patent/CN1061778A/zh active Pending
- 1991-11-22 NO NO91914584A patent/NO914584L/no unknown
- 1991-11-22 CS CS913545A patent/CS354591A3/cs unknown
- 1991-11-22 CA CA002056063A patent/CA2056063A1/en not_active Abandoned
- 1991-11-22 IE IE408191A patent/IE914081A1/en not_active Application Discontinuation
- 1991-11-22 PL PL29249891A patent/PL292498A1/xx unknown
- 1991-11-22 PT PT99585A patent/PT99585A/pt not_active Application Discontinuation
- 1991-11-22 ZA ZA919245A patent/ZA919245B/xx unknown
- 1991-11-22 KR KR1019910020895A patent/KR920009806A/ko not_active Withdrawn
- 1991-11-22 HU HU913654A patent/HU208964B/hu not_active IP Right Cessation
- 1991-11-22 JP JP3307398A patent/JPH04266877A/ja active Pending
- 1991-11-22 MX MX9102186A patent/MX9102186A/es unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100709257B1 (ko) * | 2005-08-30 | 2007-04-19 | 삼성에스디아이 주식회사 | 연료 공급장치 및 이를 포함하는 연료 전지 시스템 |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA919245B (en) | 1992-07-29 |
| NO914584L (no) | 1992-05-25 |
| HUT63621A (en) | 1993-09-28 |
| HU208964B (en) | 1994-02-28 |
| MX9102186A (es) | 1992-07-08 |
| IE914081A1 (en) | 1992-06-03 |
| FI915495A0 (fi) | 1991-11-21 |
| FI915495L (fi) | 1992-05-25 |
| FI915495A7 (fi) | 1992-05-25 |
| PT99585A (pt) | 1992-10-30 |
| PL292498A1 (en) | 1992-11-16 |
| NO914584D0 (no) | 1991-11-22 |
| EP0487980A1 (de) | 1992-06-03 |
| HU913654D0 (en) | 1992-02-28 |
| CS354591A3 (en) | 1992-06-17 |
| CA2056063A1 (en) | 1992-05-25 |
| TW206218B (enExample) | 1993-05-21 |
| DE4037437A1 (de) | 1992-05-27 |
| JPH04266877A (ja) | 1992-09-22 |
| NZ240693A (en) | 1993-07-27 |
| AU8808691A (en) | 1992-05-28 |
| CN1061778A (zh) | 1992-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR920009806A (ko) | 아미노디올 유도체 | |
| WO2003028728A8 (en) | 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands | |
| ATE144421T1 (de) | Injizierbares arzneimittel und satz, die omoprazol oder verwandte verbindungenenthalten | |
| DK197685A (da) | N,3-disubstituerede-2-oxindol-1-carboxamid-derivater og farmaceutiskepraeparater indeholdende saadanne derivater samt mellemprodukter til brug ved fremstillingen deraf | |
| KR830010121A (ko) | 세팔로스포린 유도체의 제조방법 | |
| JP2003503400A5 (enExample) | ||
| KR940021063A (ko) | 퀴놀론카르복실산 유도체, 이의 제조방법 및 용도 | |
| IE38730L (en) | Heterocyclic alkyl sulphoxides | |
| FR2767525B1 (fr) | Derives biphenyliques substitues par un radical aromatique ou heteroaromatique et compositions pharmaceutiques et cosmetiques les contenant | |
| KR870004981A (ko) | 헤테로시클릭 옥소프탈라지닐 아세트산의 제조방법 | |
| SE8204237D0 (sv) | Karbostyrilforeningar, kompositioner innehallande dessa samt forfaranden for framstellning derav | |
| MA29280B1 (fr) | Forme posologique orale contenant de la rosiglitazone | |
| KR920019781A (ko) | 벤즈이미다졸류로부터 유도된 항진정 항히스타민제 | |
| TR200001872A2 (tr) | 4-[5-(4-Metilfenil-3-(triflorometil)-1H-pirazol-1-il] benzensulfonamit' in yeni kristal biçimi "Biçim I" ve bu ürünün üretilmesine ilişkin yöntem. | |
| KR900016199A (ko) | 티아졸 유도체, 그의 제조방법 및 당뇨병 합병증 치료에 있어서의 그의 용도 | |
| DK213179A (da) | Triazinderivater | |
| ATE4383T1 (de) | Antisekretorisch wirksame heterozyklische guanidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| NO158420C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive pyrimidinderivater. | |
| KR920016423A (ko) | 루코트리엔 길항제로서의 퀴놀린-함유 케토산 | |
| KR880007477A (ko) | 이미다졸 유도체 및 이의 제조방법 | |
| KR920008028A (ko) | 피리딘 유도체, 이의 제조방법 및 용도 | |
| AU556922B2 (en) | Pyridobenzodiazepinone derivatives | |
| KR900001691A (ko) | 피리다지논 유도체 | |
| AU4911385A (en) | Heterocyclic histamine H2-receptor antagonists | |
| KR850001761A (ko) | 세팔로스포린 유도체의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19911122 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |